Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection-Reference-Cited by-同舟云学术

Refractive and biometrical characteristics of children with retinopathy of prematurity who received laser photocoagulation or intravitreal ranibizumab injection

Published:2022-05-12 Issue:10 Volume:260 Page:3213-3219
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Lu Xiaofeng,Zeng Xianlu,Chen Miaohong,Fan Zixin,Zheng Lei,Tian Ya,Zhang Shaochong,He Ji C.,Zhang Guoming^ORCID

Funder

Shenzhen Fund for Guangdong Provincial High-level Clinical Key Speciaties

Shenzhen Key Medical Discipline Construction Fund

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s00417-022-05663-0.pdf

Reference36 articles.

1. Higgins RD (2019) Oxygen saturation and retinopathy of prematurity. Clin Perinatol 46:593–599

2. Broxterman EC, Hug DA (2016) Retinopathy of prematurity: a review of current screening guidelines and treatment options. Missouri Med 113:187–190

3. Hartnett ME (2017) Advances in understanding and management of retinopathy of prematurity. Surv Ophthalmol 62:257–276

4. Chew EY (2015) There is level 1 evidence for intensive glycemic control for reducing the progression of diabetic retinopathy in persons with type 2 diabetes. Endocrine 49:1–3

5. Mintz-Hittner HA, Geloneck MM (2016) Review of effects of anti-VEGF treatment on refractive error. Eye Brain 8:135–140

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myopia dominance in preterm infants without and with retinopathy of prematurity: Indian Twin Cities ROP study (ITCROPS) report number 15;Acta Ophthalmologica;2024-08-16

2. A fundus image dataset for intelligent retinopathy of prematurity system;Scientific Data;2024-05-27

3. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03

4. Corneal refractive error and astigmatism in patients aged 6 to 18 years with a history of retinopathy of prematurity and birth weight of <1500 g;Japanese Journal of Ophthalmology;2023-11-25

5. Efficacy of four anti-vascular endothelial growth factor agents and laser treatment for retinopathy of prematurity: A network meta-analysis;Biomolecules and Biomedicine;2023-11-16